Malignant Mediastinal Neoplasm — Trials

Malignant Mediastinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 64
Recruiting: 37
Ph III recruiting: 1
Growth YoY: —
Industry share: 22%
Top sponsor: University of Washington
Termination share: 26.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07735533	A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies	not yet recruiting	Phase 1 / Phase 2	274	Umoja BiopharmaINDUSTRY	0	Aug 17, 2026	clinicaltrials
NCT07714421	Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients	not yet recruiting	Phase 1	20	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 20, 2026	clinicaltrials